Ropes & Gray Advises on the Launch of Kailera Therapeutics
October 11, 2024
October 11, 2024
BOSTON, Massachusetts, Oct. 11 -- Ropes and Gray, a law firm, issued the following news:
Ropes & Gray advised Kailera Therapeutics, Inc. and its investors on the establishment of the company, its $400 million Series A financing, and the worldwide (ex-China) licensing by the company of a portfolio of clinical-stage metabolic disease assets from Hengrui Pharmaceuticals, a leading Chinese pharmaceutical company.
Atlas Venture, Bain Capital Life Sciences, and RTW Invest . . .
Ropes & Gray advised Kailera Therapeutics, Inc. and its investors on the establishment of the company, its $400 million Series A financing, and the worldwide (ex-China) licensing by the company of a portfolio of clinical-stage metabolic disease assets from Hengrui Pharmaceuticals, a leading Chinese pharmaceutical company.
Atlas Venture, Bain Capital Life Sciences, and RTW Invest . . .